- Home
- MRVI vs CAN Comparison
MRVI vs CAN Comparison
Compare MRVI & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRVI | CAN |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.8M | 486.0M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MRVI | CAN |
|---|---|---|
| Price | $3.15 | $0.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $4.00 | $3.09 |
| AVG Volume (30 Days) | 1.2M | ★ 9.2M |
| Earning Date | 05-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $185,743,000.00 | N/A |
| Revenue This Year | $11.80 | N/A |
| Revenue Next Year | $7.74 | $63.64 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.67 | $0.43 |
| 52 Week High | $4.11 | $2.22 |
Technical Indicators
Market Signals| Indicator | MRVI | CAN |
|---|---|---|
| Relative Strength Index (RSI) | 41.83 | 41.17 |
| Support Level | $2.88 | $0.43 |
| Resistance Level | $3.99 | $0.55 |
| Average True Range (ATR) | 0.21 | 0.04 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 17.03 | 14.25 |
Price Performance
Historical ComparisonAbout MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.